Cargando…
Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians
BACKGROUND: Despite the rapid widespread use of a high-flow nasal cannula (HFNC) during the COVID-19 pandemic, its indications and appropriate use as perceived by physicians remain poorly known. METHODS: In September 2021, we sent a questionnaire to each respiratory physician from 15 institutions in...
Autores principales: | Koyauchi, Takafumi, Suzuki, Yuzo, Inoue, Yusuke, Hozumi, Hironao, Karayama, Masato, Furuhashi, Kazuki, Fujisawa, Tomoyuki, Enomoto, Noriyuki, Inui, Naoki, Suda, Takafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Respiratory Society. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464591/ https://www.ncbi.nlm.nih.gov/pubmed/36153288 http://dx.doi.org/10.1016/j.resinv.2022.08.007 |
Ejemplares similares
-
Pulse oximetric saturation to fraction of inspired oxygen (SpO(2)/FIO(2)) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease
por: Koyauchi, Takafumi, et al.
Publicado: (2020) -
Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non–Small Cell Lung Cancer After Nivolumab Therapy
por: Karayama, Masato, et al.
Publicado: (2022) -
Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the BRAF mutation
por: Watanabe, Hirofumi, et al.
Publicado: (2022) -
Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy
por: Karayama, Masato, et al.
Publicado: (2021) -
Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report
por: Mochizuka, Yasutaka, et al.
Publicado: (2022)